-
1
-
-
84929452695
-
Antimicrobial peptides and peptidomimetics-potent therapeutic allies for staphylococcal infections
-
Mohammad, H., Thangamani, S., Seleem, M. N. Antimicrobial peptides and peptidomimetics-potent therapeutic allies for staphylococcal infections. Current pharmaceutical design 21, 2073-2088 (2015).
-
(2015)
Current Pharmaceutical Design
, vol.21
, pp. 2073-2088
-
-
Mohammad, H.1
Thangamani, S.2
Seleem, M.N.3
-
2
-
-
44149103169
-
Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus
-
Stryjewski, M. E., Chambers, H. F. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 46 Suppl 5, S368-377, doi: 10.1086/533593 (2008).
-
(2008)
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
, vol.46
, Issue.5
, pp. S368-S377
-
-
Stryjewski, M.E.1
Chambers, H.F.2
-
3
-
-
77951224305
-
Chronic wounds and the medical biofilm paradigm
-
48-50, 52-43
-
Wolcott, R. D. et al. Chronic wounds and the medical biofilm paradigm. Journal of wound care 19, 45-46, 48-50, 52-43 (2010).
-
(2010)
Journal of Wound Care
, vol.19
, pp. 45-46
-
-
Wolcott, R.D.1
-
4
-
-
2942522970
-
Paul-Ehrlich-Society for, C. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: Results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001
-
Kresken, M., Hafner, D., Schmitz, F. J., Wichelhaus, T. A., Paul-Ehrlich-Society for, C. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001. International journal of antimicrobial agents 23, 577-581, doi: 10.1016/j. ijantimicag.2003.11.007 (2004).
-
(2004)
International Journal of Antimicrobial Agents
, vol.23
, pp. 577-581
-
-
Kresken, M.1
Hafner, D.2
Schmitz, F.J.3
Wichelhaus, T.A.4
-
5
-
-
48349087831
-
Antimicrobial peptides and the skin immune defense system
-
Schauber, J., Gallo, R. L. Antimicrobial peptides and the skin immune defense system. J. Allergy Clin. Immunol. 122, 261-266, doi: http://dx.doi.org/10.1016/j.jaci.2008.03.027 (2008).
-
(2008)
J. Allergy Clin. Immunol.
, vol.122
, pp. 261-266
-
-
Schauber, J.1
Gallo, R.L.2
-
6
-
-
84877849172
-
Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens
-
Deslouches, B. et al. Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens. Antimicrob. Agents Chemother. 57, 2511-2521, doi: 10.1128/AAC.02218-12 (2013).
-
(2013)
Antimicrob. Agents Chemother.
, vol.57
, pp. 2511-2521
-
-
Deslouches, B.1
-
7
-
-
84888439590
-
Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic betasheet forming peptide amphiphiles
-
Ong, Z. Y. et al. Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic betasheet forming peptide amphiphiles. Biomaterials 35, 1315-1325, doi: 10.1016/j.biomaterials.2013.10.053 (2014).
-
(2014)
Biomaterials
, vol.35
, pp. 1315-1325
-
-
Ong, Z.Y.1
-
8
-
-
33144454355
-
Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections
-
King, M. D. et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 144, 309-317 (2006).
-
(2006)
Ann Intern Med
, vol.144
, pp. 309-317
-
-
King, M.D.1
-
9
-
-
84896712720
-
Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States
-
Limbago, B. M. et al. Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States. Journal of clinical microbiology 52, 998-1002, doi: 10.1128/JCM.02187-13 (2014).
-
(2014)
Journal of Clinical Microbiology
, vol.52
, pp. 998-1002
-
-
Limbago, B.M.1
-
10
-
-
0035936156
-
Innate antimicrobial peptide protects the skin from invasive bacterial infection
-
Nizet, V. et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457, doi: 10.1038/35106587 (2001).
-
(2001)
Nature
, vol.414
, pp. 454-457
-
-
Nizet, V.1
-
11
-
-
44449129941
-
Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus
-
Ouhara, K. et al. Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus. The Journal of antimicrobial chemotherapy 61, 1266-1269, doi: 10.1093/jac/dkn106 (2008).
-
(2008)
The Journal of Antimicrobial Chemotherapy
, vol.61
, pp. 1266-1269
-
-
Ouhara, K.1
-
12
-
-
0036532403
-
How do bacteria resist human antimicrobial peptides
-
Peschel, A. How do bacteria resist human antimicrobial peptides? Trends in microbiology 10, 179-186 (2002).
-
(2002)
Trends in Microbiology
, vol.10
, pp. 179-186
-
-
Peschel, A.1
-
13
-
-
0032942727
-
In vitro antibacterial properties of pexiganan, an analog of magainin
-
Ge, Y. et al. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob. Agents Chemother. 43, 782-788 (1999).
-
(1999)
Antimicrob. Agents Chemother.
, vol.43
, pp. 782-788
-
-
Ge, Y.1
-
14
-
-
84923234075
-
In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms
-
Flamm, R. K. et al. In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms. Antimicrob. Agents Chemother. 59, 1751-1754, doi: 10.1128/AAC.04773-14 (2015).
-
(2015)
Antimicrob. Agents Chemother.
, vol.59
, pp. 1751-1754
-
-
Flamm, R.K.1
-
15
-
-
23044472373
-
Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: Implications for systemic applications
-
Deslouches, B. et al. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications. Antimicrob. Agents Chemother. 49, 3208-3216, doi: 10.1128/aac.49.8.3208-3216.2005 (2005).
-
(2005)
Antimicrob. Agents Chemother.
, vol.49
, pp. 3208-3216
-
-
Deslouches, B.1
-
16
-
-
33748988741
-
Tryptophan-and arginine-rich antimicrobial peptides: Structures and mechanisms of action
-
Chan, D. I., Prenner, E. J., Vogel, H. J. Tryptophan-and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochimica et biophysica acta 1758, 1184-1202, doi: 10.1016/j.bbamem.2006.04.006 (2006).
-
(2006)
Biochimica et Biophysica Acta
, vol.1758
, pp. 1184-1202
-
-
Chan, D.I.1
Prenner, E.J.2
Vogel, H.J.3
-
17
-
-
84880318497
-
Boosting salt resistance of short antimicrobial peptides
-
Chu, H. L. et al. Boosting salt resistance of short antimicrobial peptides. Antimicrob. Agents Chemother. 57, 4050-4052, doi: 10.1128/AAC.00252-13 (2013).
-
(2013)
Antimicrob. Agents Chemother.
, vol.57
, pp. 4050-4052
-
-
Chu, H.L.1
-
18
-
-
0031686776
-
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils
-
Turner, J., Cho, Y., Dinh, N. N., Waring, A. J., Lehrer, R. I. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42, 2206-2214 (1998).
-
(1998)
Antimicrob. Agents Chemother.
, vol.42
, pp. 2206-2214
-
-
Turner, J.1
Cho, Y.2
Dinh, N.N.3
Waring, A.J.4
Lehrer, R.I.5
-
20
-
-
4444316131
-
The advantage of bactericidal drugs in the treatment of infection
-
Alder, J., Eisenstein, B. The Advantage of Bactericidal Drugs in the Treatment of Infection. Curr. Infect. Dis. Rep. 6, 251-253 (2004).
-
(2004)
Curr. Infect. Dis. Rep.
, vol.6
, pp. 251-253
-
-
Alder, J.1
Eisenstein, B.2
-
21
-
-
84908227247
-
Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. Aureus disease
-
Conlon, B. P. Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease. BioEssays: news and reviews in molecular, cellular and developmental biology 36, 991-996, doi: 10.1002/bies.201400080 (2014).
-
(2014)
BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology
, vol.36
, pp. 991-996
-
-
Conlon, B.P.1
-
22
-
-
84866179937
-
Staphylococcus aureus persisters tolerant to bactericidal antibiotics
-
Lechner, S., Lewis, K., Bertram, R. Staphylococcus aureus persisters tolerant to bactericidal antibiotics. Journal of molecular microbiology and biotechnology 22, 235-244, doi: 10.1159/000342449000342449 (2012).
-
(2012)
Journal of Molecular Microbiology and Biotechnology
, vol.22
, pp. 235-244
-
-
Lechner, S.1
Lewis, K.2
Bertram, R.3
-
23
-
-
77955628762
-
Persister cells
-
Lewis, K. Persister cells. Annual review of microbiology 64, 357-372, doi: 10.1146/annurev.micro.112408.134306 (2010).
-
(2010)
Annual Review of Microbiology
, vol.64
, pp. 357-372
-
-
Lewis, K.1
-
24
-
-
33845607284
-
Persister cells, dormancy and infectious disease
-
Lewis, K. Persister cells, dormancy and infectious disease. Nature reviews. Microbiology 5, 48-56, doi: 10.1038/nrmicro1557 (2007).
-
(2007)
Nature Reviews. Microbiology
, vol.5
, pp. 48-56
-
-
Lewis, K.1
-
25
-
-
84888019629
-
Activated ClpP kills persisters and eradicates a chronic biofilm infection
-
Conlon, B. P. et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503, 365-370, doi: 10.1038/nature12790 (2013).
-
(2013)
Nature
, vol.503
, pp. 365-370
-
-
Conlon, B.P.1
-
26
-
-
0346492817
-
Persister cells and tolerance to antimicrobials
-
Keren, I., Kaldalu, N., Spoering, A., Wang, Y., Lewis, K. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230, 13-18, doi: 10.1016/s0378-1097(03)00856-5 (2004).
-
(2004)
FEMS Microbiol. Lett.
, vol.230
, pp. 13-18
-
-
Keren, I.1
Kaldalu, N.2
Spoering, A.3
Wang, Y.4
Lewis, K.5
-
27
-
-
78650293305
-
Targeting bacterial membrane function: An underexploited mechanism for treating persistent infections
-
Hurdle, J. G., O'Neill, A. J., Chopra, I., Lee, R. E. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nature reviews. Microbiology 9, 62-75, doi: 10.1038/nrmicro2474 (2011).
-
(2011)
Nature Reviews. Microbiology
, vol.9
, pp. 62-75
-
-
Hurdle, J.G.1
O'Neill, A.J.2
Chopra, I.3
Lee, R.E.4
-
28
-
-
80053910254
-
Staphylococcus aureus biofilms: Properties, regulation, and roles in human disease
-
Archer, N. K. et al. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2, 445-459, doi: 10.4161/viru.2.5.17724 (2011).
-
(2011)
Virulence
, vol.2
, pp. 445-459
-
-
Archer, N.K.1
-
29
-
-
0035014383
-
Mechanisms of biofilm resistance to antimicrobial agents
-
Mah, T. F., O'Toole, G. A. Mechanisms of biofilm resistance to antimicrobial agents. Trends in microbiology 9, 34-39 (2001).
-
(2001)
Trends in Microbiology
, vol.9
, pp. 34-39
-
-
Mah, T.F.1
O'Toole, G.A.2
-
30
-
-
77958021478
-
Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window
-
Wolcott, R. D. et al. Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. Journal of wound care 19, 320-328, doi: 10.12968/jowc.2010.19.8.77709 (2010).
-
(2010)
Journal of Wound Care
, vol.19
, pp. 320-328
-
-
Wolcott, R.D.1
-
31
-
-
0020043039
-
Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis
-
Christensen, G. D. et al. Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis. Annals of internal medicine 96, 1-10 (1982).
-
(1982)
Annals of Internal Medicine
, vol.96
, pp. 1-10
-
-
Christensen, G.D.1
-
32
-
-
77955593345
-
Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms
-
Singh, R., Ray, P., Das, A., Sharma, M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. The Journal of antimicrobial chemotherapy 65, 1955-1958, doi: 10.1093/jac/dkq257 (2010).
-
(2010)
The Journal of Antimicrobial Chemotherapy
, vol.65
, pp. 1955-1958
-
-
Singh, R.1
Ray, P.2
Das, A.3
Sharma, M.4
-
33
-
-
79956219045
-
Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus
-
Dean, S. N., Bishop, B. M., van Hoek, M. L. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC microbiology 11, 114, doi: 10.1186/1471-2180-11-114 (2011).
-
(2011)
BMC Microbiology
, vol.11
, pp. 114
-
-
Dean, S.N.1
Bishop, B.M.2
Van Hoek, M.L.3
-
34
-
-
77950345996
-
Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: Is combination therapy the answer
-
Nguyen, H. M., Graber, C. J. Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer? J. Antimicrob. Chemother. 65, 24-36, doi: 10.1093/jac/dkp377 (2010).
-
(2010)
J. Antimicrob. Chemother.
, vol.65
, pp. 24-36
-
-
Nguyen, H.M.1
Graber, C.J.2
-
35
-
-
84951130723
-
Antibacterial evaluation of synthetic thiazole compounds in vitro and in vivo in a methicillin-resistant staphylococcus aureus (MRSA) skin infection mouse model
-
Mohammad, H., Cushman, M., Seleem, M. N. Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model. PloS one 10, e0142321, doi: 10.1371/journal. pone.0142321 (2015).
-
(2015)
PloS One
, vol.10
, pp. e0142321
-
-
Mohammad, H.1
Cushman, M.2
Seleem, M.N.3
-
36
-
-
84865056525
-
The human milk protein-lipid complex HAMLET sensitizes bacterial pathogens to traditional antimicrobial agents
-
Marks, L. R., Clementi, E. A., Hakansson, A. P. The human milk protein-lipid complex HAMLET sensitizes bacterial pathogens to traditional antimicrobial agents. PloS one 7, e43514, doi: 10.1371/journal.pone.0043514 (2012).
-
(2012)
PloS One
, vol.7
, pp. e43514
-
-
Marks, L.R.1
Clementi, E.A.2
Hakansson, A.P.3
-
37
-
-
84877032645
-
Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLET
-
Marks, L. R., Clementi, E. A., Hakansson, A. P. Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLET. PloS one 8, e63158, doi: 10.1371/journal.pone.0063158 (2013).
-
(2013)
PloS One
, vol.8
, pp. e63158
-
-
Marks, L.R.1
Clementi, E.A.2
Hakansson, A.P.3
-
38
-
-
1242307761
-
Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35
-
Minahk, C. J., Dupuy, F., Morero, R. D. Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35. The Journal of antimicrobial chemotherapy 53, 240-246, doi: 10.1093/jac/dkh079 (2004).
-
(2004)
The Journal of Antimicrobial Chemotherapy
, vol.53
, pp. 240-246
-
-
Minahk, C.J.1
Dupuy, F.2
Morero, R.D.3
-
39
-
-
70349238995
-
Esculentin-1b(1-18)-a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli
-
Marcellini, L. et al. Esculentin-1b(1-18)-a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli. The FEBS journal 276, 5647-5664, doi: 10.1111/j.1742-4658.2009. 07257.x (2009).
-
(2009)
The FEBS Journal
, vol.276
, pp. 5647-5664
-
-
Marcellini, L.1
-
41
-
-
33644850786
-
Intracellular Staphylococcus aureus and antibiotic resistance: Implications for treatment of staphylococcal osteomyelitis
-
Ellington, J. K. et al. Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitis. Journal of orthopaedic research: official publication of the Orthopaedic Research Society 24, 87-93, doi: 10.1002/jor.20003 (2006).
-
(2006)
Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society
, vol.24
, pp. 87-93
-
-
Ellington, J.K.1
-
42
-
-
0029803527
-
Penetration of vancomycin into human lung tissue
-
Cruciani, M. et al. Penetration of vancomycin into human lung tissue. J. Antimicrob. Chemother. 38, 865-869 (1996).
-
(1996)
J. Antimicrob. Chemother.
, vol.38
, pp. 865-869
-
-
Cruciani, M.1
-
43
-
-
33645026902
-
Cellular pharmacodynamics and pharmacokinetics of antibiotics: Current views and perspectives
-
Van Bambeke, F., Barcia-Macay, M., Lemaire, S., Tulkens, P. M. Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. Current opinion in drug discovery & development 9, 218-230 (2006).
-
(2006)
Current Opinion in Drug Discovery & Development
, vol.9
, pp. 218-230
-
-
Van Bambeke, F.1
Barcia-Macay, M.2
Lemaire, S.3
Tulkens, P.M.4
-
44
-
-
0035370730
-
Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: A cause for antibiotic treatment failure in a patient with darier's disease
-
von Eiff, C. et al. Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 32, 1643-1647, doi: 10.1086/320519 (2001).
-
(2001)
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
, vol.32
, pp. 1643-1647
-
-
Von Eiff, C.1
-
45
-
-
84908296966
-
Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection
-
Mohamed, M. F., Seleem, M. N. Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection. Drug design, development and therapy 8, 1979-1983, doi: 10.2147/DDDT.S72129 (2014).
-
(2014)
Drug Design, Development and Therapy
, vol.8
, pp. 1979-1983
-
-
Mohamed, M.F.1
Seleem, M.N.2
-
46
-
-
84933054771
-
Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections
-
Thangamani, S., Younis, W., Seleem, M. N. Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections. Scientific reports 5, 11596, doi: 10.1038/srep11596 (2015).
-
(2015)
Scientific Reports
, vol.5
, pp. 11596
-
-
Thangamani, S.1
Younis, W.2
Seleem, M.N.3
-
47
-
-
84960204204
-
Repurposing auranofin for the treatment of cutaneous staphylococcal infections
-
Thangamani, S., Mohammad, H., Abushahba, M. F., Sobreira, T. J., Seleem, M. N. Repurposing auranofin for the treatment of cutaneous staphylococcal infections. International journal of antimicrobial agents 47, 195-201, doi: 10.1016/j.ijantimicag.2015.12.016 (2016).
-
(2016)
International Journal of Antimicrobial Agents
, vol.47
, pp. 195-201
-
-
Thangamani, S.1
Mohammad, H.2
Abushahba, M.F.3
Sobreira, T.J.4
Seleem, M.N.5
-
48
-
-
84938850641
-
Repurposing celecoxib as a topical antimicrobial agent
-
Thangamani, S., Younis, W., Seleem, M. N. Repurposing celecoxib as a topical antimicrobial agent. Frontiers in microbiology 6, 750, doi: 10.3389/fmicb.2015.00750 (2015).
-
(2015)
Frontiers in Microbiology
, vol.6
, pp. 750
-
-
Thangamani, S.1
Younis, W.2
Seleem, M.N.3
-
49
-
-
84946950123
-
Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent
-
Thangamani, S. et al. Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent. Scientific reports 5, 16407, doi: 10.1038/srep16407 (2015).
-
(2015)
Scientific Reports
, vol.5
, pp. 16407
-
-
Thangamani, S.1
-
50
-
-
33847020833
-
Inflammation in wound repair: Molecular and cellular mechanisms
-
Eming, S. A., Krieg, T., Davidson, J. M. Inflammation in wound repair: molecular and cellular mechanisms. The Journal of investigative dermatology 127, 514-525, doi: 10.1038/sj.jid.5700701 (2007).
-
(2007)
The Journal of Investigative Dermatology
, vol.127
, pp. 514-525
-
-
Eming, S.A.1
Krieg, T.2
Davidson, J.M.3
-
51
-
-
84879816895
-
Local inflammation exacerbates the severity of Staphylococcus aureus skin infection
-
Montgomery, C. P. et al. Local inflammation exacerbates the severity of Staphylococcus aureus skin infection. PloS one 8, e69508, doi: 10.1371/journal.pone.0069508 (2013).
-
(2013)
PloS One
, vol.8
, pp. e69508
-
-
Montgomery, C.P.1
-
52
-
-
79960845616
-
Immunity against Staphylococcus aureus cutaneous infections
-
Miller, L. S., Cho, J. S. Immunity against Staphylococcus aureus cutaneous infections. Nat. Rev. Immunol. 11, 505-518, doi: 10.1038/nri3010 (2011).
-
(2011)
Nat. Rev. Immunol.
, vol.11
, pp. 505-518
-
-
Miller, L.S.1
Cho, J.S.2
-
54
-
-
56749150574
-
Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: A randomized, controlled, double-blinded, multicenter trial of pexiganan cream
-
Lipsky, B. A., Holroyd, K. J., Zasloff, M. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 47, 1537-1545, doi: 10.1086/593185 (2008).
-
(2008)
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
, vol.47
, pp. 1537-1545
-
-
Lipsky, B.A.1
Holroyd, K.J.2
Zasloff, M.3
-
55
-
-
84954348442
-
Investigational drugs to treat methicillin-resistant Staphylococcus aureus
-
Vuong, C., Yeh, A. J., Cheung, G. Y., Otto, M. Investigational drugs to treat methicillin-resistant Staphylococcus aureus. Expert opinion on investigational drugs, 1-21, doi: 10.1517/13543784.2016.1109077 (2015).
-
(2015)
Expert Opinion on Investigational Drugs
, pp. 1-21
-
-
Vuong, C.1
Yeh, A.J.2
Cheung, G.Y.3
Otto, M.4
-
57
-
-
84903138381
-
Targeting methicillin-resistant Staphylococcus aureus with short saltresistant synthetic peptides
-
Mohamed, M. F., Hamed, M. I., Panitch, A., Seleem, M. N. Targeting methicillin-resistant Staphylococcus aureus with short saltresistant synthetic peptides. Antimicrobial agents and chemotherapy 58, 4113-4122, doi: 10.1128/AAC.02578-14 (2014).
-
(2014)
Antimicrobial Agents and Chemotherapy
, vol.58
, pp. 4113-4122
-
-
Mohamed, M.F.1
Hamed, M.I.2
Panitch, A.3
Seleem, M.N.4
-
58
-
-
84960155188
-
Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
-
Thangamani, S. et al. Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens. Scientific reports 6, 22571, doi: 10.1038/srep22571 (2016).
-
(2016)
Scientific Reports
, vol.6
, pp. 22571
-
-
Thangamani, S.1
-
59
-
-
84928781973
-
Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci
-
Mohammad, H., Mayhoub, A. S., Cushman, M., Seleem, M. N. Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci. The Journal of antibiotics 68, 259-266, doi: 10.1038/ja.2014.142 (2015).
-
(2015)
The Journal of Antibiotics
, vol.68
, pp. 259-266
-
-
Mohammad, H.1
Mayhoub, A.S.2
Cushman, M.3
Seleem, M.N.4
-
60
-
-
85014202598
-
Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogs
-
Mohamed, M. F., Hammac, G. K., Guptill, L., Seleem, M. N. Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogs. PloS one 9, e116259, doi: 10.1371/journal. pone.0116259 (2014).
-
(2014)
PloS One
, vol.9
, pp. e116259
-
-
Mohamed, M.F.1
Hammac, G.K.2
Guptill, L.3
Seleem, M.N.4
|